Fund Holdings — Caligan Partners LP

Total Portfolio Value:
$315.47M
Total Bought:
$28.72M
Total Sold:
$173.31M
Net Transaction:
-$144.60M
Notable People:
Caligan Partners Gp Llc
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Liquidia Corporation(LQDA)10,360,9458,118,592-2,242,353$124.33M$81.19M25.73%-$43.15M
Verona Pharma PlcADS1,843,7561,436,878-406,878$26.66M$41.34M13.10%+$14.68M
Exelixis, Inc.(EXEL)1,525,7301,525,7300$34.28M$39.59M12.55%+$5.31M
Evolus, Inc.(EOLS)2,167,7902,193,488+25,698$23.52M$35.53M11.26%+$12.01M
Anika Therapeutics Inc1,435,9931,435,130-863$36.37M$35.45M11.24%-$926.0K
Agios Pharmaceuticals, Inc.(AGIO)514,711579,717+65,006$22.19M$25.76M8.16%+$3.56M
BioCryst Pharmaceuticals, Inc.(BCRX)4,598,7372,583,585-2,015,152$28.42M$19.64M6.22%-$8.78M
Y-Mabs Therapeutics Inc582,0781,195,253+613,175$7.03M$15.72M4.98%+$8.69M
Mineralys Therapeutics, Inc.(MLYS)745,758981,155+235,397$8.73M$11.88M3.77%+$3.16M
NovaBridge BiosciencesADS(NBP)3,374,7913,499,330+124,539$5.64M$4.34M1.38%-$1.30M
Enanta Pharmaceuticals, Inc.(ENTA)1,042,889322,453-720,436$13.53M$3.34M1.06%-$10.19M
Outlook Therapeutics, Inc.(OTLK)500,000318,699-181,301$3.69M$1.70M0.54%-$1.99M
Alimera Sciences Inc16,835,1540-16,835,154$93.60M$0—-$93.60M
Page 1 of 1